January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
July 2025
The global next-generation cancer therapeutics market size was evaluated at USD 86.20 billion in 2024 and is predicted to hit around USD 175.20 billion by 2034, growing at a CAGR of 7.35%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
June 2025
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
July 2026
The global genomics in cancer care market size was evaluated at USD 24.39 billion in 2025 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
July 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
July 2026
Discover the future of healthcare with digital therapeutics and connected care market empowering patients with smarter, tech-enabled treatment tools.
July 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
July 2026
The global mental health digital therapeutics (DTx) market size is growing as digital tools revolutionize mental health treatment through evidence-based software.
June 2026
The US peptide therapeutics market size was evaluated at USD 21.24 billion in 2025 and is predicted to hit around USD 34.98 billion by 2035, growing at a CAGR of 5.12%.
June 2026
The global brain health supplements and therapeutics market size accounted for USD 18.60 billion in 2025 and is predicted to hit around USD 47.37 billion by 2035, growing at a CAGR of 9.80%.
June 2026
The global alzheimer therapeutics market size is evaluated at USD 6.49 billion in 2025 and is predicted to hit around USD 38.61 billion by 2035, growing at a CAGR of 19.52%.
June 2026
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,611.83 million 2035 increasing from USD 823.30 million in 2025, with a CAGR of 18.80%.
June 2026
The global rheumatology therapeutics market size is evaluated at USD 51.82 billion in 2025 and is predicted to hit around USD 68.49 billion by 2035, growing at a CAGR of 2.83%.
June 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
June 2026
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 2,023.79 million by 2035, growing at a CAGR of 15.58%.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.